# Eisai, Inc. – FDA Inspection, Feb 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/eisai-inc/a2dda4fb-11b0-48c4-8bae-404e6e8e2162
Source feed: FDA_Inspections

> FDA inspection 1041308 of Eisai, Inc., February 16, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041308
- Company Name: Eisai, Inc.
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1271039 - 2025-05-02
- FDA Inspection 1198163 - 2023-02-09
- [FDA Inspection 965277 - 2015-12-09](https://www.keypedia.com/records/fda_inspections/eisai-inc/91c61b0b-ff73-4d59-8170-c48c8c02431d)
- FDA Inspection 922940 - 2015-04-20
- [FDA Inspection 813538 - 2013-01-17](https://www.keypedia.com/records/fda_inspections/eisai-inc/67abb28d-22d3-4612-9cee-079c7e62a668)

## Related Officers

- Issuing Officer
- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)
- [FDA Associated Person](https://www.keypedia.com/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
